Back to 
BlackRock, Inc.
BlackRock, Inc.
URGN7 quarters
Position history for BlackRock, Inc.'s holdings in UROGEN PHARMA LTD
BlackRock, Inc. holds 3.2M shares of URGN (UROGEN PHARMA LTD), worth $117.8M as of 2026-Q2. The position was increased (+12.5% shares). URGN represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$117.8M
Current Shares
3.2M
Total Value Change
+$91.5M
Total Shares Change
+734,250
Quarter-by-Quarter History
Other major holders of URGN: RTW INVESTMENTS, LP, MENORA MIVTACHIM HOLDINGS LTD.